Devonian Health Group Inc. DVHGF
OTC PK
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -97.51% | -94.34% | -83.08% | -87.44% | 29.43% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -97.51% | -94.34% | -83.08% | -87.44% | 29.43% |
| Cost of Revenue | -100.44% | -92.50% | -87.60% | -99.91% | 15.03% |
| Gross Profit | -92.44% | -98.69% | -73.61% | -71.51% | 65.21% |
| SG&A Expenses | -8.64% | 8.37% | -20.55% | -49.36% | 30.01% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 5.45% | 5.75% | 2.59% | 5.96% | 0.00% |
| Total Operating Expenses | -70.37% | -67.36% | -61.08% | -80.59% | 23.49% |
| Operating Income | -6,531.46% | -1,048.48% | -175.58% | -128.38% | 89.85% |
| Income Before Tax | 58.13% | -1,196.20% | -152.89% | -129.14% | -1,126.72% |
| Income Tax Expenses | -- | -- | -- | -102.19% | -- |
| Earnings from Continuing Operations | 58.13% | -907.30% | -152.89% | -149.82% | -610.75% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 58.13% | -907.30% | -152.89% | -149.82% | -610.75% |
| EBIT | -6,531.46% | -1,048.48% | -175.58% | -128.38% | 89.85% |
| EBITDA | -3,510.39% | -781.09% | -218.95% | -124.76% | 131.55% |
| EPS Basic | 62.64% | -799.54% | -126.01% | -149.84% | -607.34% |
| Normalized Basic EPS | -5,169.84% | -1,078.28% | -126.07% | -129.14% | 109.00% |
| EPS Diluted | 62.64% | -799.54% | -126.01% | -149.84% | -607.34% |
| Normalized Diluted EPS | -5,169.84% | -1,078.28% | -126.07% | -129.14% | 109.83% |
| Average Basic Shares Outstanding | 12.07% | 11.95% | 11.87% | -0.01% | 0.47% |
| Average Diluted Shares Outstanding | 12.07% | 11.95% | 11.87% | -0.01% | -8.10% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |